HCV Core, HRP

Hepatitis C Virus Core, Horseradish Peroxidase Recombinant
Shipped with Ice Packs
In Stock

Description

The E.coli derived recombinant HRP Labeled protein contains the HCV core nucleocapsid immunodominant regions, amino acids 2-119. HCV Core is fused to b-gal (114 kDa) at N-terminus.

Product Specs

Introduction
Hepatitis C virus (HCV) is a small (50nm), enveloped, single-stranded RNA virus with a positive sense genome. It belongs to the family Flaviviridae. HCV is characterized by a high replication rate, producing approximately one trillion particles daily in an infected individual. The virus's RNA polymerase lacks proofreading ability, resulting in a high mutation rate. This contributes to HCV's ability to evade the host's immune response. HCV is classified into six genotypes (1-6), each with several subtypes. The prevalence and distribution of these genotypes vary globally. Genotype determination is clinically significant as it influences the potential response to interferon-based therapy and the required treatment duration. Genotypes 1 and 4 show a lower response rate to interferon-based treatment compared to genotypes 2, 3, 5, and 6.
Description
The recombinant HCV Core protein, derived from E. coli, encompasses the immunodominant regions of the HCV core nucleocapsid, specifically amino acids 2-119. This HCV Core protein is fused to b-gal (114 kDa) at its N-terminus and is labeled with horseradish peroxidase (HRP).
Purity
The purity of the HCV Core HRP protein exceeds 95%, as determined by 10% SDS-PAGE and Coomassie blue staining.
Formulation
The HCV Core HRP protein is provided at a concentration of 1 mg/ml in a buffer solution consisting of 20mM Tris-HCl (pH 8.0) and 8M urea.
Stability
For optimal stability, the HCV Core HRP protein should be stored at temperatures below -18°C. While the protein remains stable at 4°C for up to one week, repeated freeze-thaw cycles should be avoided.
Applications
The HCV Core HRP antigen is suitable for use in various immunological assays, including enzyme-linked immunosorbent assays (ELISA) and Western blots. Its high specificity for HCV makes it an excellent antigen for detecting the virus with minimal cross-reactivity.
Purification Method
HCV Core protein was purified by proprietary chromatographic technique.
Specificity
Immunoreactive with sera of HCV-infected individuals.

Q&A

What is the HCV core protein and why is it significant in HCV research?

The HCV core protein is a structural protein essential for viral genome encapsidation and plays crucial roles in multiple pathogenic processes including steatosis, immune evasion, and hepatocellular carcinoma development. As one of the most conserved HCV proteins, it represents an ideal target for both diagnostic applications and therapeutic interventions. The core protein's involvement in multiple cellular pathways makes it central to understanding HCV pathogenesis .

How does the structure of HCV core protein relate to its function?

The HCV core protein consists of distinct domains with specific functions. The N-terminal region (amino acids 16-36) interacts specifically with host proteins such as DDX3X both in vitro and in vivo, contributing to viral replication . The core protein contains a conserved PLXG motif (residues 84-87) that serves as a binding site for antibodies, which has implications for immunological detection and therapeutic targeting . Its structural features enable interactions with various host cellular pathways, particularly those involved in immune modulation and cell proliferation.

What are the standard methods for detecting HCV core protein in research settings?

Detection of HCV core protein typically employs immunoassay-based techniques where horseradish peroxidase (HRP) conjugated antibodies serve as detection reagents. The most common methods include:

MethodSensitivityApplicationTime Required
ELISA75% correlation with HCV RNADiagnostic screening2-3 hours
Western BlotHigh specificityProtein characterization1-2 days
ImmunohistochemistryCell-level detectionTissue localization1-2 days
Fluorescence microscopySubcellular localizationIntracellular tracking3-4 hours

HCV core antigen ELISA assays can detect the protein approximately 23.7 days post-infection, compared to 20.4 days for RNA detection and 56.5 days for antibody detection, making core protein detection valuable for early diagnosis .

How do HRP-conjugated detection systems compare with other enzyme labels for HCV core protein research?

HRP-conjugated antibody systems offer several advantages in HCV core protein detection compared to alternative enzyme labels. The oxidative catalysis by HRP produces chromogenic, chemiluminescent, or fluorescent signals depending on the substrate used, providing flexibility in detection approaches. In comparative studies, HRP-based detection systems demonstrate superior sensitivity for HCV core antigen compared to alkaline phosphatase systems, with detection limits that closely approach those of nucleic acid testing. This sensitivity is particularly critical during the preseroconversion window period when antibody tests remain negative but viral particles are present .

What are the methodological considerations when developing an HCV core antigen assay using HRP detection?

When developing HCV core antigen assays with HRP detection systems, several critical factors must be considered:

  • Antibody selection: Antibodies targeting conserved epitopes (such as the PLXG motif at residues 84-87) ensure broad genotype coverage .

  • Signal amplification: HRP signal amplification techniques can significantly improve detection sensitivity, with enhanced chemiluminescent substrates providing lower detection thresholds.

  • Cutoff determination: Statistical analysis of negative controls is essential for establishing reliable cutoff values. For instance, one validated assay established a cutoff value of 0.118 based on mean absorbance plus 3 standard deviations from 400 negative samples .

  • Sample preparation: Proper sample handling procedures must be standardized to maintain protein integrity and prevent cross-contamination.

  • Validation against PCR: New assays should be validated against HCV RNA detection, with studies showing good correlation (K = 0.51) between core antigen detection and RNA positivity .

How can researchers optimize the sensitivity of HRP-based detection for low concentration HCV core protein samples?

Optimizing sensitivity for HRP-based detection of low concentration HCV core protein requires a multifaceted approach:

  • Signal enhancement strategies:

    • Employ tyramide signal amplification (TSA) to increase HRP signal output

    • Utilize enhanced chemiluminescent substrates with higher quantum yield

    • Implement polymer-HRP conjugates carrying multiple enzyme molecules per antibody

  • Antibody selection and engineering:

    • High-affinity antibodies like scFv42C that target conserved epitopes demonstrate superior detection limits

    • Antibody fragments (scFv) can sometimes provide better access to core protein epitopes

  • Pre-analytical sample concentration:

    • Ultracentrifugation techniques to concentrate viral particles

    • Affinity capture methods to isolate core protein from complex matrices

  • Sandwich assay optimization:

    • Careful selection of capture and detection antibody pairs targeting non-overlapping epitopes

    • Optimized blocking and washing steps to minimize background signal

These optimizations can significantly improve detection limits, potentially approaching the sensitivity of molecular techniques .

How can researchers effectively use HCV core protein detection to study viral-host interactions?

Researchers can leverage HRP-labeled detection systems to investigate viral-host interactions through several methodological approaches:

  • Co-immunoprecipitation studies: Using HRP-conjugated antibodies against HCV core protein to identify and quantify binding partners after pull-down assays. This approach has successfully demonstrated the interaction between core protein and host proteins like DDX3X .

  • Subcellular localization: Immunofluorescence combined with confocal microscopy can track core protein distribution within cells. When expressed alone, specific antibodies like scFv42C display diffuse cytoplasmic fluorescence, but shift their subcellular distribution when co-expressed with core protein, indicating direct interaction .

  • Signaling pathway analysis: HRP-based western blotting can quantify changes in phosphorylation states of signaling molecules affected by core protein, such as the MAPK/ERK pathway or STAT phosphorylation .

  • Fluorescence resonance energy transfer (FRET): This technique provides independent verification of intracellular associations between antibody fragments and core protein, offering spatial resolution below the diffraction limit .

  • Chemokine induction studies: Measuring core protein-induced secretion of chemokines like CCL2 and CXCL10 via HRP-based ELISA systems can elucidate inflammatory mechanisms .

What methodological approaches help address data inconsistencies when quantifying HCV core protein levels?

When faced with inconsistent results in HCV core protein quantification, researchers should implement the following methodological controls and considerations:

  • Reference standard validation:

    • Use recombinant HCV core protein standards with verified concentration

    • Implement multiple dilution points to ensure linearity of detection

  • Multiple detection methods:

    • Cross-validate results between different detection platforms (e.g., ELISA and Western blot)

    • Compare core protein detection with HCV RNA quantification to establish correlation patterns

  • Internal controls:

    • Include spike-in recovery controls to validate extraction efficiency

    • Implement housekeeping controls when analyzing cell-based experiments

  • Statistical considerations:

    • Apply appropriate statistical tests such as McNemar χ2 test and kappa test to analyze correlation between different detection methods

    • Calculate intra-assay and inter-assay coefficients of variation (CV) to assess reproducibility

  • Pre-analytical variables:

    • Standardize sample collection, storage conditions, and freeze-thaw cycles

    • Document time delays between sample collection and processing

A comprehensive study evaluating HCV core antigen detection demonstrated that apparent discrepancies with RNA detection (K = 0.51) could be attributed to samples from early infection with lower viral titers, highlighting the importance of considering the infection stage when interpreting results .

How can single-chain variable fragment (scFv) antibodies against HCV core protein be developed and evaluated?

Development and evaluation of scFv antibodies against HCV core protein involves a systematic process:

  • Generation methodology:

    • Phage display technology using bone marrow plasma cells from patients with chronic hepatitis C provides a source of human antibodies with high specificity

    • Alternative methods include yeast display or mammalian cell surface display systems

  • Binding characterization:

    • Epitope mapping to identify binding sites (e.g., the PLXG motif at residues 84-87 of core protein)

    • Affinity determination using surface plasmon resonance or bio-layer interferometry

    • Cross-reactivity testing against different HCV genotypes

  • Functional evaluation:

    • Assess intracellular expression patterns through fluorescence microscopy

    • Verify target association using FRET techniques

    • Quantify impact on core protein levels in cellular models

    • Evaluate reversal of core protein-induced cell proliferation

  • Optimization for therapeutic potential:

    • Enhance stability through framework modifications

    • Improve intracellular folding efficiency

    • Test various delivery systems for cellular penetration

Studies have shown that high-affinity scFv antibodies like scFv42C can effectively sequester HCV core protein, reducing its levels intracellularly and reversing its pathogenic effects on cell proliferation .

What are the advantages and limitations of HCV core antigen detection compared to RNA-based methods for early diagnosis?

HCV core antigen detection offers both advantages and limitations compared to RNA-based methods:

ParameterHCV Core Antigen DetectionHCV RNA Detection
Time to detection post-infection23.7 days average20.4 days average
Sensitivity in window period75% of RNA-positive samplesGold standard (100%)
Equipment requirementsStandard ELISA readerSpecialized PCR equipment
Technical expertiseMinimal to moderateSubstantial
Cost per testLowerHigher
Turnaround time2-3 hours6-24 hours
Risk of contaminationLowHigher
Suitability for resource-limited settingsGoodLimited

The average interval between first detection of HCV RNA and core antigen is approximately 3.3 days, while both markers appear approximately 36.0 and 32.8 days before antibody seroconversion, respectively . While HCV core antigen detection doesn't match the absolute sensitivity of nucleic acid testing, its practical advantages make it valuable for screening applications, particularly in settings where PCR testing is impractical or for high-throughput screening needs.

How does HCV core protein influence macrophage polarization and function?

HCV core protein exerts significant effects on macrophage polarization and functionality through several mechanisms:

  • Inhibition of differentiation:

    • Blocks monocyte differentiation to both M1 and M2 macrophages through TLR2-mediated pathways

    • Impairs STAT signaling pathways crucial for macrophage polarization

  • Functional impairment:

    • Reduces phagocytosis activity in both M1 and M2 macrophages

    • Inhibits M1 macrophage-induced CD4+ T cell activation

    • Paradoxically enhances M2 macrophage-induced CD4+ T cell activation

  • Inflammatory response modulation:

    • Induces substantial upregulation of chemokines CCL2 (27-fold) and CXCL10 (179-fold) in macrophages

    • Activates the NF-κB signaling pathway through interaction with gC1qR receptor

These alterations contribute to immune dysfunction and may facilitate viral persistence by disrupting normal macrophage functions that would otherwise contribute to viral clearance. Research methodologies to study these interactions typically employ human macrophage cell lines (MΦ-THP-1), mouse macrophage lines (RAW 264.7), primary Kupffer cells, and peritoneal macrophages with HCV core protein treatment followed by functional assays and gene expression analysis .

What experimental designs best capture the interaction between HCV core protein and host immune signaling pathways?

Optimal experimental designs to study HCV core protein interactions with host immune signaling incorporate multiple complementary approaches:

  • Transcriptomic profiling:

    • PCR array analysis reveals broad patterns of gene expression changes (45 upregulated, 2 downregulated genes in one study)

    • Heat map visualization identifies clusters of co-regulated genes affected by core protein

    • Real-time quantitative PCR validation of key targets like chemokines CCL2 and CXCL10

  • Signaling pathway dissection:

    • Phosphorylation analysis of STAT proteins and MAPK/ERK pathway components

    • Inhibitor studies targeting specific nodes in signaling cascades

    • Nuclear translocation assays for transcription factors like NF-κB

  • Protein-protein interaction studies:

    • Co-immunoprecipitation of core protein with host factors

    • FRET analysis for direct in vivo interaction verification

    • Domain mapping to identify critical interaction interfaces

  • Functional validation:

    • siRNA knockdown of candidate interaction partners

    • Expression of mutant core proteins with altered interaction capabilities

    • In vitro and cellular assays measuring functional endpoints (e.g., chemokine secretion)

  • Statistical approach:

    • Multiple independent experiments with data expressed as mean ± standard deviation

    • Analysis using appropriate tests (Student's t-test or ANOVA) with significance threshold of p<0.05

These comprehensive approaches have successfully identified mechanisms such as the core protein-gC1qR interaction leading to CCL2 and CXCL10 induction through NF-κB signaling , providing insights into how HCV manipulates host immunity.

What are the most promising future directions for HCV core protein research using advanced detection methods?

Future research on HCV core protein using advanced detection methods shows particular promise in several key areas:

  • Next-generation diagnostics:

    • Development of point-of-care assays with sensitivity approaching nucleic acid testing

    • Multiplex systems detecting core protein alongside other viral antigens and host biomarkers

    • Digital ELISA platforms with single-molecule detection capabilities

  • Therapeutic applications:

    • Further development of intracellular antibodies (intrabodies) like scFv42C that can sequester core protein

    • Combination approaches targeting core protein alongside other viral factors

    • Delivery systems to efficiently transport core-targeting molecules into infected cells

  • Fundamental viral-host interactions:

    • Comprehensive mapping of core protein interactome across different cell types

    • Temporal dynamics of core protein functions during different stages of viral lifecycle

    • Structural biology approaches to understand conformational changes during interactions

  • Immunomodulatory mechanisms:

    • Deeper understanding of how core protein manipulates specific immune cell populations

    • Identification of therapeutic targets to reverse core protein-mediated immune dysfunction

    • Investigation of core protein's role in extrahepatic manifestations of HCV infection

Each of these research directions benefits from advances in detection methodology, particularly those employing HRP-based systems that combine sensitivity with practical laboratory implementation.

How can integrative approaches combining multiple detection methods advance our understanding of HCV core protein's multifunctionality?

Integrative approaches combining multiple detection methods provide a more comprehensive understanding of HCV core protein's diverse functions:

  • Multi-scale analysis:

    • Combining atomic-level structural studies with cellular and tissue-level functional assays

    • Integrating in vitro biochemical assays with in vivo infection models

    • Bridging molecular interactions with clinical outcomes in patient cohorts

  • Temporal dynamics:

    • Time-course studies tracking core protein localization, interaction partners, and effects

    • Correlation between core protein detection methods at different infection stages

    • Real-time monitoring of core protein functions using reporter systems

  • Spatial resolution:

    • Advanced imaging techniques including super-resolution microscopy

    • Combined approaches using fluorescent and HRP-based detection in the same samples

    • Tissue microenvironment considerations when studying core protein effects

  • Computational integration:

    • Systems biology approaches modeling core protein's impacts on multiple pathways

    • Machine learning analysis of large datasets generated from different detection platforms

    • Predictive modeling to identify novel therapeutic targets

Product Science Overview

Hepatitis C Virus (HCV) Core Protein

The Hepatitis C Virus (HCV) is a small, enveloped, positive-sense single-stranded RNA virus belonging to the family Flaviviridae . The virus is the causative agent of hepatitis C, a disease that can lead to severe liver conditions such as cirrhosis and hepatocellular carcinoma . The HCV particle consists of a lipid membrane envelope embedded with two viral envelope glycoproteins, E1 and E2, which play crucial roles in viral attachment and entry into host cells .

The core protein of HCV is a structural protein that forms the viral nucleocapsid, which encases the viral RNA genome . This protein is highly conserved among different HCV genotypes and is essential for the virus’s replication and assembly . The core protein is composed of two domains: the N-terminal domain (D1), which is rich in basic amino acids and binds to the viral RNA, and the C-terminal domain (D2), which is involved in membrane binding . The core protein also interacts with various host cell factors, influencing cellular processes and contributing to the pathogenesis of HCV infection .

Horseradish Peroxidase (HRP)

Horseradish peroxidase (HRP) is an enzyme widely used in biochemistry and molecular biology due to its ability to catalyze the oxidation of various substrates in the presence of hydrogen peroxide . HRP is traditionally extracted from the roots of the horseradish plant (Armoracia rusticana), but recombinant production methods have been developed to produce HRP in microbial systems such as Escherichia coli . Recombinant HRP offers several advantages, including higher purity, consistency, and the ability to produce specific isoenzymes .

HRP is commonly used as a reporter enzyme in diagnostic assays, such as enzyme-linked immunosorbent assays (ELISAs), due to its high sensitivity and specificity . It is also employed in various biotechnological applications, including biosensor systems, bioremediation, and cancer therapy .

Recombinant HCV Core-HRP Fusion Protein

The recombinant HCV core-HRP fusion protein combines the HCV core protein with HRP to create a powerful tool for research and diagnostic applications. This fusion protein retains the antigenic properties of the HCV core protein, making it useful for detecting HCV-specific antibodies in patient samples . The HRP component of the fusion protein allows for easy detection and quantification using colorimetric or chemiluminescent substrates .

The production of recombinant HCV core-HRP involves cloning the gene encoding the HCV core protein and the HRP gene into an expression vector, which is then introduced into a suitable host system, such as E. coli . The fusion protein is expressed, purified, and characterized to ensure its functionality and stability .

Applications and Significance

The recombinant HCV core-HRP fusion protein has several important applications:

  1. Diagnostic Assays: It is used in ELISAs to detect HCV-specific antibodies, aiding in the diagnosis of HCV infection .
  2. Research: The fusion protein is employed in studies investigating the structure, function, and interactions of the HCV core protein .
  3. Vaccine Development: It serves as a potential candidate for vaccine development due to its immunogenic properties .

In conclusion, the recombinant HCV core-HRP fusion protein is a valuable tool in the fields of diagnostics, research, and vaccine development. Its ability to combine the antigenic properties of the HCV core protein with the enzymatic activity of HRP makes it a versatile and powerful reagent.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.